← Eichor
Study identifier: NCT07023497 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Determining the Optimal Dose of Intrathecal Morphine for Post-Cesarean Analgesia

Condition: Morphine · Cesarean Section · Postoperative Pain, Acute  ·  Sponsor: University of Ioannina

PhaseNA
Planned participants100
Who can joinFemale, 18 Years to 50 Years
Healthy volunteersYes

About this study

Using spinal or epidural anesthesia (known as neuraxial blocks) is the gold standard for pain control during childbirth, especially in cesarean sections (C-sections). However, many women experience moderate to severe pain after a C-section, which can affect both their physical and emotional well-being, and even impact their ability to care for their newborn. Unfortunately, this pain is often not treated effectively, which can lead to increased sensitivity to pain or even chronic postoperative pain. One effective way to manage this pain is by giving opioids directly into the spinal fluid (subarachnoid space). This method allows doctors to use much smaller doses than would be needed if the same medication were given through a vein, which also helps avoid many of the common side effects of opioids like respiratory depression, nausea, pruritus, and constipation. Common opioids used in this setting include fentanyl, sufentanil, and morphine. These drugs behave differently depending on their chemical properties. For example, drugs that are more fat-soluble work faster, while those that are less fat-soluble tend to last longer. Morphine, which is less fat-soluble than the others, provides strong and long-lasting pain relief. When injected spinally, its effect can last 18-24 hours, with the pain relief starting 1-2 hours after the injection. Its performance is comparable to that of epidural anesthesia or nerve blocks. Researchers have studied a wide range of spinal morphine doses …

This description comes directly from the study's public registry record.

Talk to the study team

Agathi Karakosta  ·  +306948066243  ·  akarakosta@uoi.gr

Dimitra Oikonomou  ·  +306959136713  ·  dimitra.oiknm@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital of IoanninaIoannina, Epirus, GreeceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07023497